Rolling Continuation Channel (RCC) Reports
Overview of previous funding rounds:
Rounds: 9 | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1
Overview of previous funding waves:
Waves: 6 | 5 | 4 | 3 | 2 | 1
Overview of previous funding phases:
Phases: 1
| Total | 90 Round 9 disease proposals (including HSS requests) and National Strategy Applications (NSA) in 69 different countries approved, in principle, by the Board on 10 November 2009. It is noted that the TRP funding recommendations are collectively intended to be subject to a 10% adjustment downwards for efficiency, resulting in an adjusted maximum Phase 1 upper-ceiling funding of US$ 2.38 billion. |
||||||||
| By Region | East Asia & the Pacific - US$ 473.6** million for 12 disease proposals (including HSS requests) in 7 countries |
||||||||
| By Disease | HIV US$ 1,198** million in 36 countries Tuberculosis US$ 666.6** million in 35 countries Malaria US$ 783.1** million in 19 countries |
||||||||
| Documentation |
|
||||||||
|
* USD exchange rate November 2009. ** Please note that amounts per region and disease do not include a 10% downward adjustment for efficiency anticipated to be achieved during TRP clarifications and grant negotiations. |
| Total | 110 programs in 68 countries approved in principle 8 November 2008 . It is noted that the Round 8 proposals are collectively intended to be subject to a 10% adjustment downwards for efficiency, resulting in an adjusted maximum Phase 1 upper ceiling funding of US$2.753 billion. | ||
| By Region | East Asia & the Pacific - US$ 387.4* million for 17 programs in 9 countries |
||
| By Disease | HIVUS$ 1,164* million for programs in 37 countries Malaria US$ 1,568* million programs in 28 countries Tuberculosis US$ 327* million for programs in 29 countries |
||
| Documentation |
|
||
|
* Please note that amounts per region and disease do not include a 10% downward adjustment for efficiency anticipated to be achieved during TRP clarifications and grant negotiations. |
| Total | Total approved US$ 1,119 million 73 programs in 66 countries/economies* | ||
| By Region | East Asia & the Pacific - US$ 92 million for 11 programs in 19 countries/ economies* |
||
| By Disease | HIV US$ 537 million for 26 programs in 39 countries/economies* Malaria US$ 471 million for 28 programs in 27 countries/economies Tuberculosis US$ 111 million for 19 programs in 30 countries/economies* |
||
| Documentation |
|
||
| *Including countries/economies targeted in the multi – country proposal |
| Total | Total approved US$ 846 million in 63 countries | |
| By Region | East Asia & the Pacific - US$ 107 million in 8 countries |
|
| By Disease | HIV US$ 453 million in 34 countries Malaria US$ 202 million in 19 countries Tuberculosis US$ 190 million in 34 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines PDF - 378 KB | Form DOC - 2.56 MB |
| Total | Total approved US$ 770 million in 60 countries | |
| By Region | East Asia & the Pacific - US$ 128 million in 17 countries |
|
| By Disease | HIV US$ 315 million in 25 countries HSS US$ 38 million in 3 countries Malaria US$ 202 million in 26 countries Tuberculosis US$ 213 million in 23 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines PDF - 183 KB | Form DOC - 585 KB |
| Total | Total approved US$ 1,039 million in 52 countries | |
| By Region | Africa - US$ 663 million for 34 programs
in 23 countries Asia, Middle East & North Africa - US$237 million for 23 programs in 16 countries Latin America, Caribbean & Eastern Europe - US$ 139 million for 15 programs in 13 countries |
|
| By Disease | HIV US$ 469 m in 27 countries Malaria US$ 417 m in 23 countries Tuberculosis US$ 153 m in 21 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines PDF - 82 KB | Form PDF - 208 KB |
| Total | US$ 623m for 71 programs in 61 countries | |
| By Region | Africa - US$ 365m for 34 programs in 23
countries Asia, Middle East & North Africa - US$ 127m for 15 programs in 13 countries Latin America, Caribbean & Eastern Europe - US$ 130m for 22 programs in 25 countries |
|
| By Disease | HIV US$ 362m for 31 programs in 52 countries HIV/TB US$ 27m for 2 programs in 2 countries Malaria US$ 166m for 20 programs in 20 countries Tuberculosis US$ 68m for 18 programs in 18 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines PDF - 110 KB | Form PDF - 174 KB |
| Total | US$ 866 million for 98 programs in 73 countries | |
| By Region | Africa - US$ 550m for 49 programs in 30
countries Asia, Middle East & North Africa - US$ 145m for 27 programs in 27 countries Latin America, Caribbean & Eastern Europe - US$ 171m for 22 programs in 16 countries |
|
| By Disease | HIV US$ 487m for 43 programs in 52 countries HIV/TB US$ 8m for 1 program in 1 country Integrated US$ 3m for 1 program in 1 country Malaria US$ 242m for 28 programs in 37 countries Tuberculosis US$ 126m for 25 programs in 35 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines PDF - 159 KB | Form PDF - 122 KB |
| Total | US$ 565 million for 55 programs in 36 countries | |
| By Region | Africa - US$ 308m for 27 programs in 16
countries Asia, Middle East & North Africa - US$ 151m for 18 programs in 11 countries Latin America, Caribbean & Eastern Europe - US$ 106m for 10 programs in 9 countries |
|
| By Disease | HIV US$ 326m for 26 programs in 22 countries HIV/TB US$ 55m for 4 programs in 3 countries Integrated US$ 20m for 1 program in 1 country Malaria US$ 68m for 12 programs in 12 countries Tuberculosis US$ 96m for 12 programs in 12 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines PDF - 48 KB | Form PDF - 58 KB |
| Total | US $552,040,988 in nine countries | ||
| By Country | Bangladesh - US$ 81,312,404 |
||
| By Disease | HIV and AIDS - US$ 488,669,764 |
||
| Documentation |
|
| Total | US$ 229,193,583 in six countries | ||
| By Country | Armenia - US$ 11,906,034 |
||
| By Disease | HIV and AIDS - US$ 216,937,848 |
||
| Documentation |
|
| Total | US $229,193,583 in five countries | ||
| By Country | Dominican Republic - US $45,770,388 |
||
| By Disease | HIV and AIDS - US $60,168,419 |
||
| Documentation |
|
| Total | US$ 513,349,804 in eight countries | ||
| By Country | Bulgaria - US $28,021,697 |
||
| By Disease | HIV and AIDS - US $426,505,339 |
||
| Documentation |
|
| Total | US $364,489,068 in five countries | ||
| By Country | Malawi - US$ 173,329,414 |
||
| By Disease | HIV and AIDS - US$ 232,968,175 |
||
| Documentation |
|
| Total | US$ 129,713,262 in five countries | ||
| By Country | Burundi - US$19,694,151 |
||
| By Disease | HIV and AIDS - US$ 47,187,023 |
||
| Documentation |
|
| Total | 10 applications to AMFm Phase 1 were approved on 11 November 2009. The total budget for supporting interventions across these applications was US$126.7 million. Of this, US$ 17.6 was requested in new funding from the Global Fund. The majority of funding for supporting interventions will be provided through reprogramming savings gained in participating countries' existing Global Fund malaria grants through the lower cost of artemisinin-based combination therapies (ACTs) under AMFm. | ||
| By Region | East Asia & the Pacific - 1 application approved with a total budget for supporting interventions of US$11 million (US$9.6 requested in new funding from the Global Fund) North Africa & Middle East - 1 application approved with a total budget for supporting interventions of US$2.1 million (US$1.7 million requested in new funding from the Global Fund) Sub-Saharan Africa: East Africa & Indian Ocean - 6 applications approved with a total budget for supporting interventions of US$47.8 million (US$6.3 million requested in new funding from the Global Fund) Sub-Saharan Africa: West & Central Africa - 2 applications approved with a total budget for supporting interventions of US$65.8 million (no new funding requested from the Global Fund) |
||
| Documentation |
|